Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 95, Issue 3, 2012, Pages 372-377

  Ng, Zhi Xiang ^a   Kuppusamy, Umah Rani ^a   Tajunisah, Iqbal ^a   Fong, Kenneth Choong Sian ^a   Chua, Kek Heng ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Diabetic retinopathy; Polymorphism; RAGE

Indexed keywords

ADENINE; CYTOSINE; GENOMIC DNA; THYMINE;

ADULT; AGED; ARTICLE; ASIAN; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE PRODUCT; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROMOTER REGION; RECEPTOR OF ADVANCED GLYCATION END PRODUCT GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; GENE FREQUENCY; GENOTYPE; HUMANS; MALAYSIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC;

EID: 84857239766     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.11.005     Document Type: Article

References (33)

1. Klein R., Klein B. Vision disorders in diabetes. Diabetes in America 1995, 293-338. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2nd ed. National Diabetes Data Group (Ed.).
2. Roy M.S. Diabetic retinopathy in African-Americans with type 1 diabetes: the New Jersey 725. II. Risk factors. Arch Ophthalmol 2000, 118:105-115.
3. Archer D.B. Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye 1999, 13:497-523.
4. Uhlmann K., Kovacs P., Boettcher Y., Hammes H-P., Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006, 114:275-294.
5. Varma R. Diabetic retinopathy: challenges and future directions. Am J Ophthalmol 2006, 141:539-541.
6. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2006, 83:876-886.
7. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008, 196:9-21.
8. Hudson B.I., Stickland M.H., Grant P.J. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998, 47:1155-1157.
9. JiXiong X., BiLin X., MingGong Y., ShuQin L. -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 2003, 26:2696-2697.
10. dos Santos K.G., Canani L.H., Gross J.L., Tschiedel B., Pires Souto K.E., Roisenberg I. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab 2005, 85:149-156.
11. Salman A.G., Mansour D.E., Swelem A.H., Al-Zawahary W.M., Radwan A.A. Pentosidine - a new biochemical marker in diabetic retinopathy. Ophthalmic Res 2009, 42:96-98.
12. Kalousova M., Zima T., Tesar V., Dusilova-Sulkova S., Skrha J. Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background. Mutat Res 2005, 579:37-46.
13. Kankova K., Zahejsky J., Marova I., Muzik J., Kuhrova V., Blazkova M., et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complications 2001, 15:185-192.
14. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511.
15. Globocnik Petrovic M., Steblovnik K., Peterlin B., Petrovic D. The -429T/C and -374T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin Monatsbl Augenheilkd 2003, 220:873-876.
16. Lindholm E., Bakhtadze E., Sjogren M., Cilio C.M., Groop L., Agardh C.D. The -374T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 2006, 49:2745-2755.
17. A modification of the Airlie House classification of diabetic retinopathy: Diabetic Retinopathy Study report number 7. Invest Ophthalmol Vis Sci 1981, 21:210-226. The Diabetic Retinopathy Study Research Group.
18. Early Treatment of Diabetic Retinopathy Study Research Group Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991, 98:823-833.
19. Early Treatment of Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991, 98:786-806.
20. Chua K.H., Ida H., Ng C.C., Eng T.L., Palaniappan S., Lee W.S., et al. The identification of NOD2/CARD15 mutations/variants in Malaysian patients with Crohn's disease. J Digest Dis 2009, 10:124-130.
21. Tan J.A., Lee P.C., Wee Y.C., Tan K.L., Mahali N.F., George E., et al. High prevalence of alpha and beta-thalassemia in the Kadazandusuns in East Malaysia: challenges in providing effective health care for an indigenous group. J Biomed Biotechnol 2010, 10.1155/2010/706872.
22. Kalousova M., Jachymova M., Mestek O., Hodkova M., Kazderova M., Tesar V., et al. Receptor for advanced glycation end products - soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 2007, 22:2020-2026.
23. Teh C.S.J., Chua K.H., Thong K.L. Simultaneous Differential Detection of human pathogenic and non-pathogenic Vibrio species using a multiplex PCR based on gyrB and pntA genes. J Appl Microbiol 2010, 108:1940-1945.
24. Thong K.L., Lai M.Y., Teh C.S.J., Chua K.H. Simultaneous detection of methicillin-resistant Staphylococcus aureus, Acinetobacter baumanii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa by multiplex PCR. Trop Biomed 2011, 28:21-31.
25. Chua K.H., Puah S.M., Chew C.H., Tan S.Y., Lian L.H. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 2010, 37:275-281.
26. Chua K.H., Puah S.M., Chew C.H., Wong Choon Heng, Goh Khean Lee Interaction between a novel intronic IVS3+172 variant and N29I mutation in PRSS1 gene is associated with pancreatitis in a Malaysian Chinese family. Pancreatology 2011, 11:441-444.
27. Wang Y., Vom Hagen F., Pfister F., Bierhaus A., Feng Y., Gans R., et al. Receptor for advanced glycation end product expression in experimental diabetic retinopathy. Ann N Y Acad Sci 2008, 1126:42-45.
28. Kumaramanickavel G., Ramprasad V.L., Sripriya S., Upadyay N.K., Paul P.G., Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002, 16:391-394.
29. Ramprasad S., Radha V., Mathias R.A., Majumder P.P., Rema M. Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye 2007, 21:395-401.
30. Lindholm E., Bakhtadze E., Cilio C., Agardh E., Groop L., Agardh C.D. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One 2008, 3:e2546.
31. Lu W., Feng B. The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis. Tohoku J Exp Med 2010, 220:291-297.
32. Zee R.Y., Romero J.R., Gould J.L., Ricupero D.A., Ridker P.M. Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke 2006, 37:1686-1690.
33. Kankova K., Benes P., Kuchrickova S. Functional analysis of the common haplotype in the receptor for advanced glycation end-products gene previously identified as a susceptibility factor for diabetic nephropathy. Exp Clin Endocrinol Diabetes 2010, 118:93-95.